Clinical Trials Study
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Aug 14, 2014; 20(30): 10553-10563
Published online Aug 14, 2014. doi: 10.3748/wjg.v20.i30.10553
Human liver stem/progenitor cells decrease serum bilirubin in hyperbilirubinemic Gunn rat
Cédric Maerckx, Tatiana Tondreau, Silvia Berardis, Jos van Pelt, Mustapha Najimi, Etienne Sokal
Cédric Maerckx, Tatiana Tondreau, Silvia Berardis, Mustapha Najimi, Etienne Sokal, Laboratory of Pediatric Hepatology and Cell Therapy, Université Catholique de Louvain - Institut de Recherche Expérimentale et Clinique (IRCE), 1200 Brussels, Belgium
Jos van Pelt, Katholieke Universiteit Leuven, Hepatologie, 3000 Leuven, Belgium
Author contributions: Maerckx C performed the majority of experiments and wrote the manuscript; van Pelt J contributed reagents/analytic tools and analyzed the data; Tondreau T and Najimi M designed the study; Tondreau T, Najimi M and Sokal E coordinated the study and were also involved in editing the manuscript; Berardis S performed some experiments and revised the manuscript.
Supported by Fonds pour la formation à la recherche dans l’industrie et dans l’agriculture
Correspondence to: Etienne Sokal, MD, Professor of Medicine, Laboratory of Pediatric Hepatology and Cell Therapy, Université Catholique de Louvain - Institut de Recherche Expérimentale et Clinique (IRCE), 52, Avenue Mounier - Tour Vésale +3, 1200 Brussels, Belgium. etienne.sokal@uclouvain.be
Telephone: +32-2-7641387 Fax: +32-2-7648909
Received: December 13, 2013
Revised: February 8, 2014
Accepted: March 8, 2014
Published online: August 14, 2014
Processing time: 248 Days and 16.1 Hours
Core Tip

Core tip: In this study we demonstrated the ability of adult-derived human liver stem/progenitor cells (ADHLSC) to specifically conjugate bilirubin after intraportal injection into Gunn rats a model presenting a deficient bilirubin conjugation function (homologous to human Crigler-Najjar type I syndrome). Infused-Gunn rats exhibited a metabolic effect 3 mo post-transplantation and maintained over a 6 mo period. ADHLSC engraftment into Gunn rat’s liver was demonstrated by immunohistochemistry and RTqPCR. These results suggest the potential of ADHLSC to restore a deficient metabolic function in situ.